SLC5A1 and myocardial infarction: Interestingly, although the inhibition of SGLT1 led to a decrease in myocardial reactive oxygen species (ROS) levels and enhanced phosphorylation of connexin-43, Lee et al. observed that dapagliflozin showed no inhibition of SGLT1 in a rat model of myocardial infarction.